Skip to main content
SpringerLink
Log in

Cytokines and Lung Injury

  • Conference paper
Acute Lung Injury

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 30))

Abstract

Among the many groups of mediators involved in the pathogenesis and clinical expression of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), cytokines occupy a central place. Since the discovery of the role of these substances in inflammatory processes of different types and locations of the human body, a number of experimental and clinical investigations suggest that they play an important role in ARDS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cochrane CG, Spragg R, Revak SD (1983) Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 71: 754 – 761

    Article  PubMed  CAS  Google Scholar 

  2. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE (1986) Lung neutrophil in the adult respiratory distress syndrome. Clinical and pathophysiological significance. Am Rev Respir Dis 133: 218 – 225

    PubMed  CAS  Google Scholar 

  3. Lee CT, Fein AM, Lippman M, Holtzman H, Kimbel P, Weinbaum G (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304: 192 – 196.

    Article  PubMed  CAS  Google Scholar 

  4. Mc Guire WW, Spragg RC, Cohen AB, Cochrane GG (1982) Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 69: 543 – 553

    Article  Google Scholar 

  5. Idell S, Kucich U, Fein A, (1985) Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 132: 1098 – 1105

    PubMed  CAS  Google Scholar 

  6. Tracey KJ, Lowry SF, Cerami A (1988) Cachetin/TNF-a in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 138: 1377 – 1379

    PubMed  CAS  Google Scholar 

  7. Pober JS (1988) Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 133: 426 - 433

    PubMed  CAS  Google Scholar 

  8. Libby P, Ordovas JM, Auger KR, Robbins AH, Biriyi LK, Dinarello CA (1986) Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. J Pathol 124: 179 – 185

    CAS  Google Scholar 

  9. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163: 1363 – 1375

    Article  PubMed  CAS  Google Scholar 

  10. Harmsen AG, Havell EA (1990) Roles of tumor necrosis factor and macrophages in lipopolysaccharide-induced accumulation of neutrophils in cutaneous air pouches. Infect Immun 58: 297 – 302

    PubMed  CAS  Google Scholar 

  11. Stephens KE, Ishizaka A; Larrick JW, Raffln TA (1988) Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis 137: 1364 – 1370

    PubMed  CAS  Google Scholar 

  12. Moser R, Schleiffenbaum B, Groscurth P, Fehr J (1989) Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83: 444 – 455

    Article  PubMed  CAS  Google Scholar 

  13. Goldblum SE, Sun WL (1990) Tumor necrosis factor-a augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol (Lung Cell Mol Physiol) 2: L57 – L67

    Google Scholar 

  14. Tracey KJ, Beutler B, Lowry SF, et al (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234: 470 – 474

    Article  PubMed  CAS  Google Scholar 

  15. Millar AB, Foley NM, Singer M, Johnson Mcl, Meager A, Rook GAW (1989) Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2: 712 – 724

    Article  PubMed  CAS  Google Scholar 

  16. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA (1991) Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144: 268 – 271

    PubMed  CAS  Google Scholar 

  17. Marks JD, Berman Marks C, Luce JM et al (1990) Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141: 94 – 97

    PubMed  CAS  Google Scholar 

  18. Roten R, Markert M, Feihl F, Schaller MD, Tagan MC, Perret C (1991) Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Respir Dis 143: 590 – 592

    PubMed  CAS  Google Scholar 

  19. Calandra T, Baumgartner JD, Grau GE et al (1990) and the Swiss-Dutch J5 group. Kinetics and prognostic values of tumor necrosis factor, IL-1, IFN-a and IFN-y in the serum of patients with septic shock. J Infect Dis 161:982–987

    Google Scholar 

  20. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, The J5 study group, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319: 397 – 400

    Article  Google Scholar 

  21. Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 335 – 357

    Google Scholar 

  22. Ferro TJ, Lynch J J, Malik AB (1989) Macrophages activated by fibrin increase albumin permeability across pulmonary artery endothelial monolayers. Am Rev Respir Dis 139: 940 – 945

    PubMed  CAS  Google Scholar 

  23. Dehring DJ, Wismar BL (1989) Intravascular macrophages in pulmonary capillaries of humans. Am Rev Respir Dis 139: 1027 – 1029

    PubMed  CAS  Google Scholar 

  24. Kelley J (1990) Cytokines of the lung (State of the art). Am Rev Respir Dis 141: 765 – 788

    PubMed  CAS  Google Scholar 

  25. Strieter RM, Remick DG, Lynch JP III, et al (1989) Differential regulation of tumor necrosis factor-a in human alveolar macrophages and peripheral blood monocytes: A cellular and molecular analysis. Am J Respir Cell Mol Biol 1: 57 – 63

    PubMed  CAS  Google Scholar 

  26. Rich EA, Panuska JR, Wallis RS, Wolf CB, Leonard ML, Ellner JJ (1989) Dyscoordinate expression of tumor necrosis factor-a by human blood monocytes and alveolar macrophages. Am Rev Respir Dis 139: 1010 – 1016

    PubMed  CAS  Google Scholar 

  27. Martinet Y, Yamauchi K, Crystal RG (1988) Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes. Am Rev Respir Dis 138: 650 – 665

    Google Scholar 

  28. Jacobs RF, Tabor DR, Burks AW, Campbell GD (1989) Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 140: 1686 – 1692

    PubMed  CAS  Google Scholar 

  29. Tracey KJ, Lowry SF, Cerami A (1988) Cachectin: A hormone that triggers acute shock and chronic cachexia. J Infect Dis 157: 413 – 420

    Article  PubMed  CAS  Google Scholar 

  30. Tran Van Nhieu J, Misset B, Lebargy F, Carlet J, Bernaudin JF (1993) Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome. Am Rev Respir Dis 147: 1585 – 1589

    PubMed  CAS  Google Scholar 

  31. Donnelly SC, Strieter RM, Kunkel SL, (1993) Interleukin-8 and development of adult distress syndrome in at risk patient groups. Lancet 341: 643 – 647

    Article  PubMed  CAS  Google Scholar 

  32. Okusawa S; Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effects of cyclooxy-genase inhibition. J Clin Invest 81: 1162 – 1172

    Article  PubMed  CAS  Google Scholar 

  33. Ulich TR, Yin S, Guo K, Yi ES, Remick D, Del Castillo J (1991) Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor-ß inhibit acute inflammation. Am J Pathol 138: 1097 – 1101

    PubMed  CAS  Google Scholar 

  34. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J (1994) Cytokine expression by neutrophils and macrophages in vivo: Endotoxin induces necrosis factor a, macrophage inflammatory protein 2, IL–lß and IL–6 but not RANTES or TGF–ßl mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 10: 148 – 153

    PubMed  CAS  Google Scholar 

  35. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA (1993) Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 151: 5666 – 5674

    PubMed  CAS  Google Scholar 

  36. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209 – 1220

    Article  PubMed  Google Scholar 

  37. Kunkel SL, Standiford T, Kasahara K, Strieter RM (1991) Interleukin-8 (11-8) - The major neutrophil chemotactic factor in the lung. Exp Lung Res 17: 17 – 23

    Article  PubMed  CAS  Google Scholar 

  38. Gimbrone MA, Obin MS, Brock AF, et al (1989) Endothelial interleukin-8. A novel inhibitor of leukocyte-endothelial interactions. Science 246: 1601 - 1603

    Article  PubMed  CAS  Google Scholar 

  39. Xing Z, Kirpalani H, Torry D, Jordana M, Gauldie J (1993) Polymorphonuclear leucocytes as a significant source of tumor necrosis factor-a in endotoxin challenged lung tissue. Am J Pathol 143: 1009 – 1015

    PubMed  CAS  Google Scholar 

  40. Schwartz MD, Repine JE, Abraham E (1995) Hemorrhagic shock and ARDS: Blood loss rapidly induces pulmonary cytokine expression through an oxygen-radical dependent mechanism. Crit Care Med 23: Al 10 (Abst)

    Google Scholar 

  41. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM (1991) Alveolar macrophage-de-rived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II like epithelial cells. J Biol Chem 266: 9912 – 9918

    PubMed  CAS  Google Scholar 

  42. Roberts AB, Sporn MB (1989) Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-ß. Am Rev Respir Dis 140: 1126 – 1128

    PubMed  CAS  Google Scholar 

  43. Xing Z, Jordana M, Gauldie J (1992) IL-lß and IL-6 gene expression in alveolar macrophages: Modulation by extracellular matrices. Am J Physiol 262: L600 – L605

    PubMed  CAS  Google Scholar 

  44. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR (1996) Proinflammatory activity in bronchoalveolar lavage fluid from ARDS patients: A prominent role for interleukin-1. Am J Respir Crit Care Med 153: 1850 – 1856

    PubMed  CAS  Google Scholar 

  45. Goodman RB, Strieter RM, Martin DP, et al (1996) Inflammatory cytokines in patients with presistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154: 602 – 611

    PubMed  CAS  Google Scholar 

  46. Miller EJ, Cohen AB, Nagao S, et al (1992) Elevated levels of NAP-l/Interleukin-8 are present in the airspaces of patients with the ARDS and are associated with increased mortality. Am Rev Respir Dis 146: 427 – 432

    PubMed  CAS  Google Scholar 

  47. Strieter RM, Zank K, Phan SH, Standiford TJ, Lukacs NW, Kunkel SL (1995) A role for C-C chemokines in fibrotic lung disease. L Leukoc Biol 57: 782 – 787

    Google Scholar 

  48. Donnelly SC, Strieter RM, Reid PT, et al (1996) The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 125: 191 – 196

    PubMed  CAS  Google Scholar 

  49. De Waal Malefyt R, Figdor CG, Huijbens R, et al (1993) Effects of IL-13 on phenotype, cyto-kine production, and cytotoxic function of human monocytes. J Immunol 151: 6370 – 6381

    PubMed  Google Scholar 

  50. Chantry D, Turner M, Abney E, Feldmann M (1989) Modulation of cytokine production by transforming growth factor-p. J Immunol 142: 4295 – 4300

    PubMed  CAS  Google Scholar 

  51. Shenkar R, Coulson WF, Abraham E (1994) Anti-transforming growth factor-p monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Respir Cell Mol Biol 11: 351 – 357

    PubMed  CAS  Google Scholar 

  52. Pue CA, Mortensen RF, Marsh CB, Pope HA, Wewers MD (1996) Acute phase levels of C-re- active protein enhance IL-lp and IL-lra production by human blood monocytes but inhibit IL-lp and IL-lra production by alveolar macrophages. J Immunol 156: 1494 – 1600

    Google Scholar 

  53. Dayer JM, Isler P, Nicod LP (1993) Adhesion molecules and cytokine production. Am Rev Respir Dis 148 (Suppl S): S70 – S74

    PubMed  CAS  Google Scholar 

  54. Kang BH, Manderschied BD, Huang YCT, Crapo JD, Chang LY (1996) Contrasting response of lung parenchymal cells to instilled TNF-a and IFN-y: The inducibility of specific cell ICAM- 1 in vivo. Am J Respir Cell Mol Biol 15: 540 – 550

    PubMed  CAS  Google Scholar 

  55. Heffner JE, Repine JE (1989) Pulmonary strategies of antioxidant defense. Am Rev Respir Dis140: 531 – 554

    Google Scholar 

  56. Pacht ER, Timerman AP, Lykens MG, Merola AJ (1991) Deficiency of alveolar fluid glutathi-one in patients with sepsis and the adult respiratory distress syndrome. Chest 100: 1397 – 1403

    Article  PubMed  CAS  Google Scholar 

  57. Bunnell E, Pacht ER (1993) Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 148: 1174 – 1178

    PubMed  CAS  Google Scholar 

  58. Ishii Y, Partridge CA, Del Vecchio PJ, Malik AB (1992) Tumor necrosis factor-a mediated de-crease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H202. J Clin Invest 89: 794 – 802

    Article  PubMed  CAS  Google Scholar 

  59. Warner BB, Burhans MS, Clark JC, Wispe JR (1991) Tumor necrosis factor-a increases Mn- SOD expression: Protection against oxidant injury. Am J Physiol 260: L296 – L301

    PubMed  CAS  Google Scholar 

  60. Clancy RM, Leszczynska-Piziak J, Abramson SB (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct anion on the NADPH oxidase. J Clin Invest 90: 1116 – 1121

    Article  PubMed  CAS  Google Scholar 

  61. Motterlini R, Foresti R, Intaglietta M, Winslow RM (1996) NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270 (Heart Circ Physiol 39): H107 – H114

    PubMed  CAS  Google Scholar 

  62. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651 – 4655

    Article  PubMed  CAS  Google Scholar 

  63. Kubes P, Granger DN (1992) Nitric oxide modulates microvascular permeability. Am J Phys-iol 262 (Heart Circ Physiol 31): H611 – H615

    CAS  Google Scholar 

  64. Hill ME, Bird IN, Daniels RH, Elmore MA, Finnen MJ (1994) Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but no transmigration across IL-lp-treated en-dothelial monolyers. J Immunol 153: 3673 – 3683

    PubMed  CAS  Google Scholar 

  65. Gadaleta D, Davis JM (1994) Pulmonary failure and the production of leukotrienes. J Am Coll Surg 178: 309 – 319

    PubMed  CAS  Google Scholar 

  66. Henson PM, Barnes PJ, Banks-Schlegel SP (1992) Platelet-activation factor: Role in pulmo-nary injury and dysfunction and blood abnormalities. Am Rev Respir Dis 145: 726 – 731

    PubMed  CAS  Google Scholar 

  67. Rabinovici R, Bugelski PJ, Esser KM, Hillegass LM, Vernick J, Feuerstein G (1993) ARDS-like lung injury produced by endotoxin in platelet-activating factor-primat rats. J Appl Physiol 74: 1791 – 1802

    PubMed  CAS  Google Scholar 

  68. Matsumoto K, Taki F, Kondoh Y, Taniguchi H, Takagi K (1992) Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin Exp Pharmacol Physiol 19: 509 – 515

    Article  PubMed  CAS  Google Scholar 

  69. Hocking DC, Phillips PG, Ferro TJ, Johnson A (1990) Mechanisms of pulmonary edema in-duced by tumor necrosis factor-a. Circulation Research 67: 68 – 77

    PubMed  CAS  Google Scholar 

  70. Smith CS, Parker L, Shearer WT (1994) Cytokine regulation by platelet activating factor in a human B cell line. J Immunol 153: 3997 – 4005

    PubMed  CAS  Google Scholar 

  71. Moya FR, Hoffman DR, Zhao B, Johston JM (1993) Platelet activating factor in surfactant preparations. Lancet 341: 858 – 860

    Article  PubMed  CAS  Google Scholar 

  72. Imai Y, Kawano T, Miyasaka K, Takata M, Imai T, Okuyama K (1994) Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Car Med 150: 1550 – 1554

    CAS  Google Scholar 

  73. Campbell EJ, Senior RM, Welgus HG (1987) Extracellular matrix injury during lung inflammation. Chest 92: 161 – 167

    Article  PubMed  CAS  Google Scholar 

  74. Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue re-modeling. FASEB J 5: 2145 – 2154

    PubMed  CAS  Google Scholar 

  75. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM (1996) Matrix metalloproteinases and TIMP in acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 154: 346 – 352

    PubMed  CAS  Google Scholar 

  76. Kossodo S, Gasche Y, Ricou B, et al (1997) Do BAL fluid levels of metalloproteinases predict the development of ARDS? Am J Respir Crit Care Med (In press)

    Google Scholar 

  77. Perez RL, Roman J (1995) Fibrin enhances the expression of IL-lp by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol 154: 1879 – 1887

    PubMed  CAS  Google Scholar 

  78. Lotz M, Guerne PA (1991) Interleukin-6 induces the synthesis of tissue inhibitor of metal-loproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266: 2017 – 2020

    PubMed  CAS  Google Scholar 

  79. Lacraz S, Nicol L, Galve-de Rochemonteix B, Baumberger Ch, Dayer JM, Welgus HG (1992) Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleu- kin-4. J Clin Invest 90: 383 – 388

    Article  Google Scholar 

  80. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG (1990) Immune modulation of metallo¬proteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-y. J Clin Invest 86: 1204 – 1210

    Article  PubMed  CAS  Google Scholar 

  81. Clark JG, Milberg JA, Steinberg KP, Hudson LD (1995) Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalve-olar lavage fluid with increased risk for death. Ann Intern Med 122: 17 – 23

    PubMed  CAS  Google Scholar 

  82. Tai Y, Bazan HE, Bazan NG (1995) Platelet activating factor induces the expression of metal-loproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Invest Ophtalmol Vis Sci 36: 345 – 354

    Google Scholar 

  83. Piedboeuf B, Johnston CJ,Watkins RH,et al (1994) Increased expressionof tissue inhibitor of metalloproteinases (TIMP-I) and metallothionine in murine lungs after hyperoxic exposure. Am J Respir Cell Mol Biol 10: 123 – 132

    PubMed  CAS  Google Scholar 

  84. Fisher CJ, Dhainaut JFA, Opal SM, et al (1994) for the phase III rhlL-lra sepsis syndrome study group. Recombinant human interleukin 1 receptor antagonist in the treatment of pa-tients with sepsis syndrome. Results from a randomised, double-blind, placebo-controlled trial. JAMA 271:1836–1843

    Google Scholar 

Download references

Authors
  1. P. M. Suter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Ricou
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pulmonary and Critical Care, St. Paul Ramsey Medical Center, 640 Jackson Street, St. Paul, 55101, MN, USA

    John J. Marini

  2. Anaesthesia and Critical Care, Royal Brompton Hospital, Sydney Street, SW3 6NP, London, UK

    Timothy W. Evans

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Suter, P.M., Ricou, B. (1998). Cytokines and Lung Injury. In: Marini, J.J., Evans, T.W. (eds) Acute Lung Injury. Update in Intensive Care and Emergency Medicine, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60733-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60733-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64532-7

  • Online ISBN: 978-3-642-60733-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation